"I am thrilled to welcome Bill to the Heron team as Chief Development Officer," said Craig Collard, Chief Executive Officer of Heron. Prior to joining Heron, Dr. Forbes served as the Chief Development Officer at Trevi Therapeutics, Inc. from 2021 to 2022. Prior to that, Dr. Forbes served as the Chief Development Officer at Salix Pharmaceuticals, Inc. as the Head of Medical and R&D from 2005 to 2015. About Heron Therapeutics, Inc.Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs. Investor Relations and Media Contact:David SzekeresExecutive Vice President, Chief Operating OfficerHeron Therapeutics, Inc.[email protected]858-251-4447SOURCE Heron Therapeutics, Inc.

Source: Forbes June 12, 2023 19:02 UTC